Log In
Print
BCIQ
Print
Print this Print this
 

Ergidina, SAND 5

  Manage Alerts
Collapse Summary General Information
Company Adienne Pharma & Biotech
DescriptionRecombinant human minibody against complement component C5 (C5) fused with RGD-motif
Molecular Target Complement 5 (C5)
Mechanism of ActionComplement inhibitor
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationIschemia / reperfusion injury
Indication DetailsPrevent ischemia/reperfusion injury associated with solid organ transplantation
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today